Dimitri A Breems

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. ncbi Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype
    Dimitri A Breems
    Department of Hematology, Hospital Network Antwerp, Campus Stuivenberg, Antwerp, Belgium
    J Clin Oncol 26:4791-7. 2008
  2. ncbi Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: a prospective randomized Dutch-Belgian Haemato-Oncology Co-operative Group (HOVON)
    Dimitri A Breems
    Department of Haematology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Br J Haematol 128:59-65. 2005
  3. ncbi Autologous stem cell transplantation in the treatment of adults with acute myeloid leukaemia
    Dimitri A Breems
    Department of Haematology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Br J Haematol 130:825-33. 2005
  4. ncbi Various distinctive cytogenetic abnormalities in patients with acute myeloid leukaemia aged 60 years and older express adverse prognostic value: results from a prospective clinical trial
    Bronno van der Holt
    Department of Trials and Statistics HOVON Data Centre, Erasmus MC Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands
    Br J Haematol 136:96-105. 2007
  5. ncbi Acute myeloid leukemia and the position of autologous stem cell transplantation
    Dimitri A Breems
    Department of Hematology, Hospital Network Antwerp, General Hospital Stuivenberg, Antwerp, Belgium, and Erasmus University Medical Center, Rotterdam, The Netherlands
    Semin Hematol 44:259-66. 2007
  6. ncbi Successful treatment of systemic amyloidosis with hepatic involvement and factor X deficiency by high dose melphalan chemotherapy and autologous stem cell reinfusion
    Dimitri A Breems
    Department of Hematology, Erasmus Medical Center, Rotterdam, The Netherlands
    Eur J Haematol 72:181-5. 2004
  7. ncbi Prognostic index for adult patients with acute myeloid leukemia in first relapse
    Dimitri A Breems
    Erasmus University Medical Center, Department of Hematology, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    J Clin Oncol 23:1969-78. 2005

Collaborators

Detail Information

Publications7

  1. ncbi Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype
    Dimitri A Breems
    Department of Hematology, Hospital Network Antwerp, Campus Stuivenberg, Antwerp, Belgium
    J Clin Oncol 26:4791-7. 2008
    ..To investigate the prognostic value of various cytogenetic components of a complex karyotype in acute myeloid leukemia (AML)...
  2. ncbi Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: a prospective randomized Dutch-Belgian Haemato-Oncology Co-operative Group (HOVON)
    Dimitri A Breems
    Department of Haematology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Br J Haematol 128:59-65. 2005
    ..The results are discussed in relation to the generic problems of applying autologous transplantation and in the perspective of the limited statistical power of this and other previously published studies...
  3. ncbi Autologous stem cell transplantation in the treatment of adults with acute myeloid leukaemia
    Dimitri A Breems
    Department of Haematology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Br J Haematol 130:825-33. 2005
    ..Particular issues discussed are the value of autologous SCT in different prognostic subsets of AML and the value of autologous mobilised peripheral blood stem cell transplants, which offer a much faster haematopoietic recovery...
  4. ncbi Various distinctive cytogenetic abnormalities in patients with acute myeloid leukaemia aged 60 years and older express adverse prognostic value: results from a prospective clinical trial
    Bronno van der Holt
    Department of Trials and Statistics HOVON Data Centre, Erasmus MC Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands
    Br J Haematol 136:96-105. 2007
    ..Large studies to confirm the prognosis of individual cytogenetic aberrations are warranted...
  5. ncbi Acute myeloid leukemia and the position of autologous stem cell transplantation
    Dimitri A Breems
    Department of Hematology, Hospital Network Antwerp, General Hospital Stuivenberg, Antwerp, Belgium, and Erasmus University Medical Center, Rotterdam, The Netherlands
    Semin Hematol 44:259-66. 2007
    ..To fully appreciate the role of autologous PBSC transplantation, the results of a recently closed randomized trial must be awaited...
  6. ncbi Successful treatment of systemic amyloidosis with hepatic involvement and factor X deficiency by high dose melphalan chemotherapy and autologous stem cell reinfusion
    Dimitri A Breems
    Department of Hematology, Erasmus Medical Center, Rotterdam, The Netherlands
    Eur J Haematol 72:181-5. 2004
    ..The diagnosis and treatment of systemic amyloidosis with hepatic involvement and the management of the multifactorial coagulopathy in these cases is discussed...
  7. ncbi Prognostic index for adult patients with acute myeloid leukemia in first relapse
    Dimitri A Breems
    Erasmus University Medical Center, Department of Hematology, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    J Clin Oncol 23:1969-78. 2005
    ..CONCLUSION: The prognostic index estimates the outcome of AML patients in first relapse using four commonly applied clinical parameters and might identify patients who are candidates for salvage and investigational therapy...